Contraindicated. Coadministration of doravirine with a solid CYP3A inducer may possibly decrease doravirine plasma concentrations and/or effects. Prospective for loss of virologic response and probable resistance to doravirine. pentobarbital will minimize the extent or impact of bortezomib by aff